Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...

Biogen’s Tecfidera (dimethyl fumarate) is taken twice daily and is associated with unpleasant gastrointestinal side-effects. But Merck KGaA’s drug requires two short treatment courses ...

Merck KGaA fought for years to get the drug approved after rejection by ... which is associated with unpleasant gastrointestinal side effects. Moreover, it could also help defend Biogen’s ...

Eikon Therapeutics, a company headed by the former Merck executive who steered the cancer drug Keytruda to FDA ... and it’s a driver of certain gastrointestinal and endometrial cancers.

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

Acetaminophen is generally a safe and effective pain reliever, but it can can lead to serious side effects and liver damage ...

The manufacturer of Vioxx, Merck & Co., argued that Vioxx ... surgeries or hospitalizations avoided by the gastrointestinal benefits of this drug. At the same time, we might be able to make ...

Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial The last few ... sales expectations on Leqembi, the drug’s growth in the U.S. has remained sluggish ...

Exelixis' future depends on trial outcomes and patent risks. Find out why EXEL stock is a "Sell" despite cabozantinib's ...

SeaStar Medical has been selected to receive the 2025 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2025 Spring Clinical Meetings in ...

Johnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel ...